首页> 外文OA文献 >Transcutaneous electrical acupoint stimulation as an adjunct therapy for obsessive-compulsive disorder: A randomized controlled study
【2h】

Transcutaneous electrical acupoint stimulation as an adjunct therapy for obsessive-compulsive disorder: A randomized controlled study

机译:经皮穴位电刺激作为强迫症的辅助治疗:一项随机对照研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background:Transcutaneous electrical acupoint stimulation (TEAS) is thought to have potential to treat obsessive-compulsive disorder (OCD). Objective:The purpose of this study was to determine whether adding TEAS to cognitive behavioral therapy (CBT) and clomipramine would improve the efficacy of these conventional treatments in OCD. Methods:In this randomized controlled trial, 360 OCD patients were assigned to receive TEAS combined with CBT plus clomipramine (Group A, n = 120), TEAS combined with CBT plus placebo (Group B, n = 120), and simulated (placebo) TEAS combined with CBT plus clomipramine (Group C, n = 120) for 12 weeks. The primary outcome was measured using the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS). Results OCD symptoms in all patients reduced over time, however Groups A and B had a significantly greater reduction in Y-BOCS total score and the subscale for obsession and compulsion between week 2 and week 12 compared to Group C. Groups A and B had similar scores on these measures. Both groups had significantly higher rates of clinical response than Group C (88.3% and 81.7% vs. 67.5%, respectively, p < 0.001); and higher rates of remission (30.0% and 22.5% vs. 9.2%, respectively, p < 0.001). Group B experienced fewer adverse events than the other two groups. Conclusions:TEAS enhances the efficacy of conventional OCD interventions and avoids the adverse effects associated with conventional pharmacological treatment. It can be considered as an effective adjunct intervention for OCD.
机译:背景:经皮电穴位刺激(TEAS)被认为具有治疗强迫症(OCD)的潜力。目的:本研究的目的是确定将TEAS加入认知行为疗法(CBT)和氯米帕明是否会改善这些传统疗法在强迫症中的疗效。方法:在这项随机对照试验中,将360名强迫症患者分配为接受TEAS联合CBT加氯米帕明(A组,n = 120),TEAS联合CBT加安慰剂(B组,n = 120)并进行模拟(安慰剂) TEAS联合CBT加氯米帕明(C组,n = 120)持续12周。使用耶鲁-布朗强迫症量表(Y-BOCS)测量主要结局。结果所有患者的强迫症症状随时间推移而减轻,但是与C组相比,A组和B组的Y-BOCS总得分和痴迷和强迫子量表的降低幅度明显大于C组。A组和B组的相似性在这些措施上得分。两组的临床反应率均显着高于C组(分别为88.3%和81.7%对67.5%,p <0.001);和更高的缓解率(分别为30.0%和22.5%与9.2%,p <0.001)。 B组的不良事件少于其他两组。结论:TEAS增强了常规OCD干预的疗效,并避免了与常规药物治疗相关的不良反应。可以将其视为强迫症的有效辅助干预措施。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号